TY  - GEN
AU  - Stirban,A O
AU  - Andjelkovic,M
AU  - Heise,T
AU  - Nosek,L
AU  - Fischer,A
AU  - Gastaldelli,A
AU  - Herz,M
TI  - Aleglitazar, a dual peroxisome proliferator-activated receptor-α/γ agonist, improves insulin sensitivity, glucose control and lipid levels in people with type 2 diabetes: findings from a randomized, double-blind trial
SN  - 1463-1326
PY  - 2017///1023
KW  - Adult
KW  - Aged
KW  - Blood Glucose
KW  - metabolism
KW  - Diabetes Mellitus, Type 2
KW  - drug therapy
KW  - Double-Blind Method
KW  - Drug Administration Schedule
KW  - Fasting
KW  - blood
KW  - Glycated Hemoglobin
KW  - Humans
KW  - Hypoglycemic Agents
KW  - administration & dosage
KW  - Insulin Resistance
KW  - physiology
KW  - Insulin-Secreting Cells
KW  - Lipid Metabolism
KW  - drug effects
KW  - Metabolic Syndrome
KW  - prevention & control
KW  - Middle Aged
KW  - Oxazoles
KW  - PPAR alpha
KW  - agonists
KW  - PPAR gamma
KW  - Thiophenes
KW  - Treatment Outcome
N1  - Publication Type: Letter; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/dom.12620
ER  -